US GMP (21 CFR 820) Manufactured Oligos For Preclinical Research

If you commercialize Molecular Diagnostics (MDx), develop Laboratory Developed Tests (LDTs), or conduct preclinical research, it is imperative that your final kit, assay, or modality adheres to exceptionally high quality standards to comply with stringent regulatory and study requirements. In the case of oligonucleotide raw materials, discover why you should consider Custom cGMP Oligos.

Manufacturing oligos under cGMP mitigates risk by minimizing the likelihood of contamination, mix-ups, deviations, failures, and other errors. This, in turn, guarantees oligo products meet the strict standards of MDx, LDTs, and preclinical research.

access the Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online